Overview

MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery

Status:
Recruiting
Trial end date:
2022-12-05
Target enrollment:
Participant gender:
Summary
Compare the effect of ropivacaine versus placebo pectoral nerve block (Pecs 1 and 2) on acute pain after tumorectomy plus sentinel lymph node dissection on one day surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Institut Curie
Treatments:
Ropivacaine